Edelman and Gally (1) have recently shown that an individual's Bence Jones proteins are chemically and physically similar to the low molecular weight polypeptides (L chains) obtained by reductive cleavage of his myeloma proteins. Indeed, Putnam (2) has shown that peptide maps of the tryptic digests of oxidized Bence Jones proteins correspond to a portion of the peptide map of similarly treated autologous serum myeloma protein.
Edelman and Gally (1) have recently shown that an individual's Bence Jones proteins are chemically and physically similar to the low molecular weight polypeptides (L chains) obtained by reductive cleavage of his myeloma proteins. Indeed, Putnam (2) has shown that peptide maps of the tryptic digests of oxidized Bence Jones proteins correspond to a portion of the peptide map of similarly treated autologous serum myeloma protein.
Edelman and Benacerraf (3) have postulated that the manufacture of the L polypeptide chains is asynchronous in multiple myeloma, and thus a part of the cell output appears in the urine as Bence Jones protein, whereas other chains are incorporated into the circulating myeloma globulin. It was of interest, therefore, to examine the uncommon instance of Bence Jones proteinuria in a patient with Waldenstrdm's macroglobulinemia and particularly to compare the L chains of the serum macroglobulins and y2-globulins with the urinary Bence Jones protein.
Evidence is presented to show that the Bence Jones protein is chemically and antigenically similar to the L chain derived from the patient's macroglobulin and antigenically deficient when compared to the L chain of the autologous 7 S y2-globulin.
Materials and Methods Clinical informationt. The patient in the present study, a 74-year-old Caucasian male, was admitted to the Ear, Nose, and Throat Service of the University of California * Submitted for publication July 16, 1963 ; accepted September 19, 1963. Supported in part by grants A-1229 and B-1099 from the National Institutes of Health, Bethesda, Md., a grant from The National Foundation, and funds from the Research Committee of the University of California School of Medicine.
Medical Center, in January 1963, because of gradual, progressive loss of hearing during the preceding year. He had always been in excellent health except for several episodes of unexplained epistaxis one year before admission. In the course of the initial physical examination, hepatomegaly was detected, and initial laboratory studies revealed a 3 + proteinuria positive for Bence Jones protein and a normochromic, normocytic anemia with marked rouleaux formation. Additional laboratory studies showed a hemoglobin of 9.3 g per 100 ml, hematocrit of 29%, and leukocyte count of 5,100 per mm'. The total serum protein was 11.4 g per 100 ml; serum electrophoretic analysis showed 20% albumin and 61% y-globulin. A Sia test showed a 4+ reaction. Bone marrow aspiration detected lymphocytosis and plasmacytosis, and an X-ray bone survey demonstrated generalized demineralization.
Materials. The sodium salts of reagent grade phosphate and acetate were used for the preparation of the buffers; reagent grade urea was used. Additional materials were mercaptoethanol,1 iodoacetamide,2 carboxymethyl-cellulose (CM-cellulose, 0.8 mEq per g),3 and diethylaminoethyl-cellulose (DEAE-cellulose, 0.9 mEq per g). 3 The exchangers were recycled through acid and base washes before use. Also used were cross-linked dextran (140 to 400 mesh) 4 and a crystalline preparation of trypsin. 5 Protein analysis. Protein concentrations were estimated by optical absorption at 280 ms in 1-cm cells or by the modified Folin-Ciocalteau method (4) . One OD unit at 280 mu was assumed to be the equivalent of 1 mg of protein per ml.
Ultracentrifugation. Proteins were analyzed in the Beckman Spinco Model E analytical ultracentrifuge using schlieren optics. Sedimentation coefficients were determined by the procedures described by Schachman (5) . The sedimentation coefficients for the macroglobulins were derived by extrapolation of the experi-mentally obtained values at various concentrations to infinite dilution. The sedimentation coefficients of other protein samples were determined from data using single concentrations of the proteins. The partial specific volume was assumed to be 0.73 ml per g. All samples were dialyzed against 0.1 M NaCl and 0.01 M phosphate at pH 7 or pH 8 before centrifugation.
Isolation of the macroglobulins and 7 S y-globulins. Ultracentrifugal analysis of the patient's serum had revealed 4.5 g of protein per 100 ml having a sedimentation value of 17 S or higher. This serum was dialyzed against 0.15 M NaCl, and the macroglobulin was isolated as a precipitated euglobulin by the addition of one part of the dialyzed serum to six parts of deionized water. This mixture was allowed to remain at 40 C for approximately 1 hour before centrifugation. The macroglobulin was further purified by four more euglobulin precipitations and then characterized by analytical ultracentrifugation.
The -y2-globulin of the patient's serum was isolated from the supernatant fluid acquired during the first euglobulin precipitation. This fluid was equilibrated against 0.02 M phosphate at pH 8 and passed through a DEAEcellulose column (4.0 X 39 cm) equilibrated with the same buffer (6) . The first effluent containing diluted 7 S -y-globulin was further purified and concentrated on CM-cellulose. The final product was dialyzed against water and lyophilized.
The y2-globulin of a normal human serum was isolated by modification of the described chromatographic procedures (6) .
Isolation and purification of the urine proteins. Random urine specimens from the patient showed 0.15 g of protein per 100 ml of urine as measured by the biuret method. Twenty-four hour collections of urine were dialyzed against multiple changes of distilled water ethylenediaminetetraicetate were placed in a dialysis bag and surrounded by 100 ml of the above solvent containing the mercaptan. After reaction at room temperature for 16 to 20 hours, a fivefold molar excess of iodoacetamide was added to the contents of the dialysis bag and the apparent pH adjusted to 8 with tris(hydroxymethyl)aminomethane. After 20 minutes the reaction mixture was dialyzed against changes of water for several days. The resulting product was insoluble in both water and saline. A sample of the purified Bence Jones protein was also treated in this manner.
To obtain soluble reduction products and to examine the antigenic character of the protein fractions, reduction and alkylation were performed in 0.2 M phosphate at pH 8 in the absence of urea but with identical concentrations of the other reactants used in the above procedure (8) . After alkylation, the protein was dialyzed against 0.1 M NaCl solutions. When very small amounts of protein were available, the dialysis against the reducing agent was eliminated during reduction.
Dissociation and isolation of light chains of the macroglobulin. The reduced and alkylated y-globulin proteins obtained by both methods of reduction mentioned above were dissociated by dialysis against 7 M urea with 0.05 M phosphate, apparent pH 6 (8) .
Separation of the L chains from the heavy polypeptide chains (H chains) (3) was achieved by gel filtration in a manner modified but similar to that used in the separation of components of y2-globulin by Fleischman, Pain, and Porter (9) . Columns containing Sephadex (G-100) equilibrated with 7 M urea and 0.05 M phosphate (apparent pH 6) were prepared immediately before use. Samples of the reduced and alkylated macroglobulins in the urea buffer were applied to the columns. Elution with the same buffer yielded two peaks on analysis by the Folin method. The second peak was dialyzed against 0.1 M NaCl buffered at pH 8 and then against water and concentrated by lyophilization. Under similar conditions the reduction products of 7 S 72-globulin, reduced and alkylated in buffers containing no urea, were isolated.
Starch gel electrophoresis. Vertical starch gel electrophoresis in urea at pH 3 was performed in a manner essentially as described by Edelman and Poulik (8) with the modification that the concentration of urea in the gel was 7 M. Electrophoresis was conducted at 40 C for 16 to 20 hours at a gradient of 6 to 7 v per cm.
Peptide mapping of the proteins. One to lio suspensions of the lyophilized L chain of the macroglobulin or the Bence Jones protein previously reduced and alkylated in urea were reacted with trypsin in 0.02 M ammonium acetate at pH 8.6 for 18 hours at 37°. The trypsin to protein ratio was approximately 1 to 50. A slight precipitate remaining in each of the samples was removed by centrifugation. The samples were then lyophilized to total dryness.
Solutions containing approximately 1.5 to 2.0 mg of the trypsin digest were applied to Whatman 3MM paper (46 X 57 cm) at one position. The peptides were separated by electrophoresis in an acetic acid-pyridine buffer (acetic acid 10: pyridine 1: water 189) at pH 3.6 in the (10) . Descending chromatography in the second dimension was performed using an n-butanol: acetic acid: water (120: 30: 50) solvent.
Peptides were detected by dipping the paper in 0.25%o triketohydrindene hydrate (Ninhydrin) in acetone, heating the paper to 60 to 700 C for 15 minutes, and observing the development of the spots over a period of 48 hours. Photographs were taken after 48 hours of development.
Immunnological techniques. Double-diffusion analysis was performed in agar buffered with a barbital buffer, y = 0.075, pH 8.6. Immunoelectrophoresis was performed by standard techniques at this ionic strength and pH. A horse antihuman serum, a specific horse antihuman 'y1-A (P2A),6 and a rabbit antiserum to human^I-globulin were used in this study.
Results
Characterization of the isolated macroglobulin. Ultracentrifugal examination of a 3.5% solution of the purified macroglobulin indicated no components with a sedimentation coefficient less than 17 S. The macroglobulin showed three components ( Figure 1A ). The sedimentation coefficients S20,w for the two slowest components were 6 Hyland Laboratories, Los Angeles, Calif. Gel filtration chromatography of each of these preparations on Sephadex G-100 in 7 M urea yielded a fraction that was excluded from the gel and one that entered the gel, the latter peaks being the L chains ( Figure 3 ). As judged by the protein distribution, about 21% of the protein was in the second peak.
Separation of the two peaks in the case of the macroglobulin reduced in the absence of urea was virtually complete (Figure 3 ). However, separation of the components of the macroglobulin reduced in urea yielded some overlap of the two peaks. In these cases, rechromatography of the second peak under the same conditions was at times considered necessary.
The L chain of the macroglobulin reduced in the presence of urea was insoluble in saline and Electrophoresis in urea-starch gel. In Figure   4 is seers the pattern of the various protein preparations after electrophoresis in urea-starch gel at pH 3. Under these conditions the purified macroglobulin ( Figure 4-1) showed a total inability to penetrate the starch gel and no indication of breaking into smaller and more mobile subunits.
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::,.,, The macroglobulin reduced and alkylated in urea gave two well-stained bands (Figure 4-2) , the more rapid band (L chain) penetrating the gel about twice as far as the other band (H chain). There were several less well-stained bands apparent.
The L chain isolated by gel filtration from the reduced macroglobulin (Figure 4-4) had the identical mobility of the more rapid component of this macroglobulin (Figure 4-2) . This L chain preparation appeared to be free of the other components present in the reduced parent macroglobulin.
The Bence Jones protein reduced and alkylated in urea (Figure 4-3) showed the same mobility as the fast component of the macroglobulin or the isolated L chain of this macroglobulin reduced and alkylated under similar conditions (Figure 4-2, 4) .
The macroglobulin reduced and alkylated in the absence of urea (Figure 4-6 ) also showed two strongly stained bands in addition to three faint bands. The more mobile component (L chain) of this preparation penetrated further into the gel than did the corresponding L chain of the macroglobulin reduced in the presence of urea. The unreduced and unmodified Bence Jones protein (Figure 4-5) showed a rapid mobility in the gel and appeared to have the identical mobility of the L chain of the macroglobulin reduced and alkylated in the absence of urea.
Peptide mapping. Comparison of the Bence Jones protein with the L chain of the macroglobulin was performed by peptide mapping. Electrophoresis and chromatography of the trypsin hydrolysate of the Bence Jones protein and the L chain of the macroglobulin yielded apparently identical "fingerprints" (Figure 5a, b) Immunodiffusion. Figure 6 shows the results of the diffusion of the Bence Jones protein and various soluble light chain preparations against a rabbit antiserum to human Fraction II. A line of complete identity appeared between the Bence Jones protein and the soluble light chain obtained from the macroglobulin, which is of antigenic Type I.7 The light chain of the patient's 72-globulin produced strong spur formation across the macroglobulin L chain and the Bence Jones protein. The precipitin line of the latter two proteins fused with the precipitin line of the 72-globulin L chain and showed no spur formation beyond the 72-globulin precipitin line. The L chain of the patient's y2-globulin formed a line of complete identity with the L chain of a 72-globulin obtained from a normal person. The faint precipitin band near the wells containing the L chain of the patient's 72-globulin is unexplained.
Discussion
The results of the present study are an extension of existing information on the structural relationships of Bence Jones proteins and serum myeloma proteins. Studies relating Bence Jones protein to the serum myeloma protein have been in terms of the S or slow fragment obtained by papain treatment (11) (12) (13) (14) (15) and the L polypeptide chain obtained by reduction and alkylation of the purified serum protein (1, 16, 17) . Antigenic differences between Bence Jones protein and the S fragment of autologous myeloma protein have been demonstrated (18) . By double diffusion methods, the L chain of myeloma protein does show a reaction of partial identity with the S fragment of the same protein; however, the L chain more closely resembles the autologous Bence Jones protein than does the S fragment (19) . Indeed, Edelman and Gally (1) and showed similar amino acid compositions. The L chain prepared from this myeloma protein that had been reduced in the absence of urea was compared with the Bence Jones protein and showed similar thermosolubility characteristics. Similarly prepared L chains of normal 72-globulin also show thermosolubility characteristics of Bence Jones proteins and thus demonstrate a fundamental similarity between an intrinsic structural component of 72-globulins and the urinary Bence Jones proteins (1) .
Myeloma proteins and the autologous Bence Jones proteins usually have the same antigenic configuration in that they are either Type I or II (20) and InV(+) or InV(-) (21, 22) , suggesting a similarity of cellular or clonal origin.
Normal y2-globulin appears to be a mixture of the antigenic Types I and II (23) , and recent evidence indicates that both these types also appear in macroglobulins obtained from normal serum (24) , reflecting presumably the normal heterogeneity of cellular origin of both classes of -y-globulins.
Miacroglobulinemia with Bence Jones proteinuria is distinctly less common than multiple myeloma and this proteinuria (25 The differences in mobility and solubility noted between the L chains of the macroglobulin prepared by reduction and alkylation in the absence or presence of urea undoubtedly reflect a difference in the extent of reduction of disulfide bonds in these polypeptides. Reduction of proteins by mercaptans in the presence of urea is more extensive than in the absence of urea (28) . When pathologic macroglobulin was reduced with mercaptoethanol, many more disulfide bonds were broken with the macroglobulin reduced in the presence of urea than in the absence of urea (8) . In all probability, the L chain obtained from the macroglobulin reduced in the presence of urea represents a far more extensively reduced product than the L chain produced by reduction of the macroglobulin that was not in the presence of urea.
In our own work, comparison of the L chains of the macroglobulin with the Bence Jones protein by double diffusion established the antigenic identity of the two proteins. In addition, the spur formation shown by the patient's own 72-globulin L chains with the Bence Jones protein and the L chain of the macroglobulin indicated the presence of determinants of both Types I and II in the patient's 72-globulin. The L chain of the y2-globulin did not have antigenic deficiencies when compared to the L chain of the /2-globulin obtained from a normal serum and by this criterion, therefore, appeared to be normal. Investigation of the normal population of macroglobulin molecules in this patient was not considered feasible.
The evidence presented here indicates that the patient's lymphoid cells are producing large amounts of unique macroglobulins belonging to antigenic Type I. In addition, this same cell line probably is producing the Bence Jones protein that is chemically and antigenically indistinguishable from the L chain of the macroglobulin.
Other cells of the lymphoid series are producing y2-globulin of Types I and II that are presumably normal. The findings are consistent with the concept that a certain population of lymphoid cells, probably arising from a single clone of cells, has extensively proliferated in this patient and is committed to the manufacture of a limited number of unique macroglobulin proteins belonging to one antigenic group. This case represents a situation parallel to that in multiple myeloma, where much evidence has strongly suggested that both myeloma proteins and Bence Jones proteins are produced from a clone of cells that have extensively proliferated (29) . Indeed, in this case of the transplantable mouse plasma-cell tumors' producing myeloma protein, the production of these proteins is directly related to the weight of the tumor (29) . In addition, some of these mouse myeloma tumors also produce Bence Jones protein. Askonas and Fahey (30) have shown that the Bence Jones protein was neither a precursor nor a breakdown product of the myeloma protein in one of these mouse tumors. Putnam and Hardy (31) have found that Bence Jones proteins were not breakdown products of the myeloma protein. The data are consistent with the view that Bence Jones proteins are manufactured at a rate independent of the myeloma proteins. Edelman and Benacerraf (3) have postulated that the uncontrolled asynchronous synthesis of the L chain of myeloma protein is responsible for the appearance of Bence Jones protein in the urine.
An over-all similarity between macroglobulinemia with Bence Jones proteinuria and myeloma and its corresponding proteinuria (26) appears to exist. There has been no definitive evidence to date that the distinctive 7 S or 19 S proteins of these diseases are abnormal. Rather it is distinctly possible that these several serum proteins and Bence Jones proteins are expressions of some regulatory dysfunction of an otherwise normal population of lymphoid cells. The Bence Jones proteinuria of macroglobulinemia is far rarer than the proteinuria of myeloma (25) . Whether this fact represents a difference in the mechanism leading to increased synthesis of L chains or decreased synthesis of H chains is not known. With the establishment of additional qualitative similarities between normal serum and urinary proteins and the proteins associated with these two diseases, future studies should be directed toward the basic mechanisms regulating the rate of synthesis of y-globulins and Bence Jones proteins. 91 DALE GROSS AND WALLACE V. EPSTEIN Summary A comparison was made between the serum and urine proteins isolated from a patient with Waldenstr6m's macroglobulinemia and Bence Jones proteinuria. After reduction and alkylation in a solvent containing no denaturing agent, the macroglobulin was separated into H and L chains by gel filtration on urea-Sephadex G-100. The L chain of the macroglobulin and the Bence Jones protein had similar thermosolubility characteristics and sedimentation values on analytic ultracentrifugation.
On electrophoresis in urea-starch gel, the unmodified Bence Jones protein had the identical mobility of the L chain of the macroglobulin. L chains and Bence Jones protein prepared by reduction in urea buffers had identical but slower mobilities than the proteins reduced in buffers without urea. Peptide maps of these proteins appeared to be identical.
The L polypeptide chain of the serum macroglobulin and the urinary Bence Jones protein were both of Type I, whereas the L chain of the autologous serum y2-globulin manifested both Types I and II antigenic specificity.
This study strongly suggests the chemical and immunologic identity of a Bence Jones protein and the L chain of the autologous serum macroglobulin.
